Appletree CI Group

Winterthur, Switzerland Founded: 2013 • Age: 13 yrs Acquired By TFS
A contract research organization with experience in development of ophthalmology drugs and medical devices

About Appletree CI Group

Appletree CI Group is a Healthcare company based in Winterthur (Switzerland) founded in 2013, and was acquired by TFS in January 2023. A contract research organization with experience in development of ophthalmology drugs and medical devices. Its chief executive, as recorded, is Georg Mathis. Appletree CI Group offers products and services including Clinical Development, Resourcing Solutions, and Functional Services (FSP). Its focus areas include Biopharma Outsourcing, CRO, Clinical Development and Full Service.

Company details

Appletree CI Group is a contract research organisation serving the medical device, pharmaceutical and biotech industries. Service offering includes medical writing, biostatistics, legal representation, quality assurance, pharmacovigilance services, document management, clinical trial authorizations, and consulting. The company has operations in 9 European countries and also in therapeutic areas such as dermatology, paediatric investigations. The company was formed by the merger of Appletree AG and Clinical Investigations in April 2013. The merged company bought Brunner and Hess, a Swiss biostatistics and data management company in January 2014.

Key Metrics

Products & Services of Appletree CI Group

Appletree CI Group offers a comprehensive portfolio of products and services, including Clinical Development, Resourcing Solutions, and Functional Services (FSP).

Clinical Development
Research Services

Services for clinical trials from phases I-III

Resourcing Solutions
Staffing Services

Flexible staffing for pharmaceutical projects

Functional Services (FSP)
Outsourcing

End-to-end clinical workforce management solutions

Apps and channels of Appletree CI Group

its YouTube channel TFS HealthScience has 35 subscribers and 30 videos.

TFS HealthScience
YouTube 35 subscribers 30 videos Science & Technology
Open channel

Videos from Appletree CI Group

The most watched videos on Appletree CI Group's YouTube channel, TFS HealthScience (35 subscribers). Click a video to play it here.

We are TFS HealthScience
269 views
TFS CDS: Rare Diseases and Orphan Drugs
227 views
World Quality Week 2022 Featuring Bharanitharan Rajendran and Heather Wells
189 views
World Quality Week 2022 Featuring Stacy Keller and Sukhi Saggu
175 views

More on TFS HealthScience.

Investors in Appletree CI Group

Appletree CI Group has secured backing from 1 investor. Prominent investors backing the company include TFSCRO.

All
InvestorDescriptionFounded YearDomainLocation
Clinical research services are provided globally by TFS CRO.
1996tfscro.comLund, Sweden
Premium access

Investor details for Appletree CI Group

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Appletree CI Group

1 people are tracked at Appletree CI Group (1 in leadership).

NameRoleGroup
Georg Mathis
CEO & PresidentLeadership
Premium access

Complete people profiles for Appletree CI Group

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Appletree CI Group

2 dated milestones of Appletree CI Group across 10 years, from founding to its latest funding, stage changes and deals.

  1. Founded Appletree CI Group is founded.
  2. Exit Acquired by TFS.
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Appletree Ci Group

Premium access

Complete news archive for Appletree CI Group

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Appletree CI Group

Appletree CI Group was founded in 2013.

Appletree CI Group is headquartered in Winterthur, Switzerland. It is registered at Winterthur, Zurich, Switzerland.

Georg Mathis is the CEO of Appletree CI Group, as recorded in our data.

Appletree CI Group is a contract research organisation serving the medical device, pharmaceutical and biotech industries. Service offering includes medical writing, biostatistics, legal representation, quality assurance, pharmacovigilance services, document management, clinical trial authorizations, and consulting. The company has operations in 9 European countries and also in therapeutic areas such as dermatology, paediatric investigations. The company was formed by the merger of Appletree AG and Clinical Investigations in April 2013. The merged company bought Brunner and Hess, a Swiss biostatistics and data management company in January 2014.

Appletree CI Group offers Clinical Development, Resourcing Solutions, and Functional Services (FSP).

Appletree CI Group has 1 investor. Key investors include TFSCRO.

Yes. Appletree CI Group was acquired by TFS in January 2023.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available